Purpose: The impact of postoperative complications on survival after radical surgery for esophageal, gastric, and colorectal cancers remains controversial. We conducted a systematic review of recent publications to examine the effect of postoperative complications on oncological outcome.
gastroesophageal and pancreatic cancer surgery. 10 One possible explanation for this phenomenon is that the changes in patient immunological responses trigger the progression of residual disease into a clinically manifest recurrence. 11 Some research has shown a negative impact of postoperative complications on survival outcomes. However, several other studies have concluded that surgical complications have no negative effect on survival rates and that these rates depend exclusively on the pathological stage of the tumor. 12 Lerut et al. 13 have reported that the modified Clavien classification, in addition to the microscopic residual tumor and extracapsular lymph node involvement, is a useful prognostic indicator of early recurrence and its timing. They have noted that achieving esophagectomy without postoperative complications is of utmost importance because of their potential negative effect on early oncological outcomes. 13 Recent advances in endoscopic diagnosis and clinical radiology in Japan allow early detection of gastric cancer, and therapeutic strategies have been established in some clinical trials.
D2 lymph node dissection is safely carried out with low mortality and morbidity and provides favorable oncological outcomes. 12, 13 However, in clinical practice, postoperative complications do occur,
causing some practical problems including longer hospital stay, excessive weight loss with sarcopenia, psychological damage, and delay of adjuvant chemotherapy in advanced cases. The incidence of postoperative complications as a detrimental prognostic factor has recently attracted considerable attention. The impact of postoperative complications on oncological outcomes has also been investigated in patients undergoing colorectal cancer resection. However, the results have been inconsistent. In 2011, Mirnezami et al.
14 published a meta-analysis of the effects of anastomotic leakage on oncological outcomes. They concluded that anastomotic leakage has a negative prognostic impact on local recurrence and cancer-specific survival.
Acute lung injury induced by the overproduction of inflammatory cytokines can lead to pneumonia after esophageal surgery. 15, 16 For the improvement of long-term survival, it is essential to minimize mortality by optimizing surgical techniques and perioperative care. [17] [18] [19] In addition, severe infections, pulmonary complications, and liver dysfunction require extended intensive care and long hospital stays for some patients. 9, 20 A history of such postoperative complications increases the likelihood of poor survival. The effect of body mass index (BMI) on oncological outcomes after major resection for cancer has also been investigated. [21] [22] [23] Although the majority of the studies show a significant association between high BMI and postoperative morbidity, the association of BMI with longterm oncological outcomes is still controversial. The effects of BMI and postoperative complications might differ depending on the type of operation and/or the type of cancer. Esophageal cancer surgery is probably one of the most stressful types of surgery. Moreover, postoperative complications after esophagectomy can sometimes be fatal.
In the present study, we re-evaluated the clinical impact of postoperative morbidity on oncological outcome by systematically reviewing recent publications (from 2011 onward), mainly focusing on long-term patient survival. In addition, we discuss possible mechanisms of this phenomenon. With the present review, we hope to develop a foundation for future guidelines of Japanese Association 
| Data extraction
Key messages and information were extracted from each article and organized by the authors. In order to evaluate the impact of postoperative complications on long-term survival, we conducted a publication-based meta-analysis. The following information from the eligible articles was used: authors, title, countries of origin, publication year, total sample size, study design, study period, variables used for the statistical adjustment, definition of complication, conclusion, and the summary statistics (hazard ratios and their 95% confidence intervals
[CI]) for outcomes. Primary outcome measure of the meta-analysis was OS. Postoperative complications were evaluated using the Clavien-Dindo classification. 24 Complications with Clavien-Dindo grade II or higher were defined as severe complications.
| Statistical analysis
For the meta-analysis, quantitative data were pooled using the random effects inverse variance weighted meta-analysis in STATA 13
(StataCorp, College Station, TX, USA). If the adjusted hazard ratio was not reported or it was missing, we treated it as missing and did not include it in the summary statistics calculations. The hazard ratio and the corresponding 95% CI for OS were calculated for each study to compare patients with and without postoperative complications.
Heterogeneity between the trials and groups of studies was measured using the I 2 statistics, which indicate the percentage of variance in a meta-analysis that is attributable to the study heterogeneity. 25 All reported P-values are two-tailed and P-values <0.05
were considered statistically significant.
| RESULTS

| Studies included in the present review
Our systematic search identified 372 articles using PubMed and 871 articles using MEDLINE. We manually found one additional eligible paper and included it in our analysis. We considered 80 stud- Intense postoperative inflammatory response frequently observed in patients with severe postoperative pneumonia is significantly correlated with poor postoperative survival. Therefore, the oncological benefit of reducing postoperative inflammation in esophageal cancer should be investigated. 27 Based on risk stratification for esophagectomy using a Japanese nationwide database, Takeuchi et al.
34
observed that the 30-day and operative mortality rates were lower than those in previously published reports. The risk models developed in their study might contribute to improvements in procedure quality control and the establishment of a novel scoring system. Several studies have reported a negative impact of postoperative complications on patient prognosis after gastric cancer surgery using multivariate analysis. [35] [36] [37] [38] [39] Table 2 and Figure 2 show the summarized results of studies evaluating the prognostic impact of postoperative complications. All eligible studies reported adjusted hazard ratios obtained using multivariate analysis; the overall hazard ratio was 1.59 (95% CI, 1.13-2.24), with a statistically significant heterogeneity (P < 0.0001). In each study, postoperative complications were defined by a Clavien-Dindo grade higher than II, [35] [36] [37] which was observed in 10.3-14.5% of the studied patients. There were no apparent differences between the incidences of postoperative complications among large-volume institutions in Japan. It is not clear from these reports if the occurrence of such complications was limited to Clavien-Dindo grades III or higher (more severe complications). The prognoses of OS, 35, 39 relapse-free survival (RFS), 36 both OS and oncological outcome, 37 and both OS and RFS 38 were evaluated. We found reports on the negative impact of postoperative complications on patient prognosis for every stage of gastric cancer, 36 stage III gastric cancer, 37 and stages II and III gastric cancers. 38 Cancer-related death is not commonly observed in the early stages of gastric cancer; thus, its negative impact on RFS might be characteristic of stage III gastric cancer patients.
However, some studies have found that postoperative complications do not always have a negative impact on prognosis. | 13 conducted in Spain, the incidence of postoperative complications (Clavien-Dindo grade II or higher) was reported as 59.8%, which is somewhat higher than that reported elsewhere. [36] [37] [38] They have concluded that these complications do not have a negative impact on oncological outcome. However, regional differences and patient background might be important in the interpretation of the incidence of postoperative complications.
In some reports, the incidence of postoperative complications is evaluated as a negative prognostic factor that affects not only the OS, but also the RFS of gastric cancer patients after curative surgery.
In gastric cancer surgery, the major postoperative complications are Another hypothesis must also be considered. If particularly frail patients with potentially poor prognoses easily develop postoperative complications, the incidence of these complications might not be an independent negative prognostic factor. Preoperative nutritional statuses of patients might contribute to this 'frailty'. Prognostic nutritional index I has been evaluated as a predictor of postoperative complications and poor prognosis. 39 The hazard ratio of preoperative nutritional index for prognosis might be offset by the hazard ratio of postoperative complications. Jiang et al. have
reported that postoperative complications are significant negative prognostic factors despite the negative impact of prognostic nutritional index shown in a multivariate analysis. 39 In order to elucidate this phenomenon, the effect of prognostic nutritional index on the incidence of postoperative complications and patient survival should be studied in a large-scale prospective setting. Table 3 45-55 . These studies were cohort studies that con- 
| Prognostic impact of BMI on postoperative morbidity and long-term survival (Table 4)
Multivariate analyses carried out in various studies have shown that preoperative BMI is an independent prognostic factor for reduced survival, and that it is strongly associated with postoperative complications in esophageal cancer. 59 Wang et al. 60 have reported that preoperative BMI is an independent prognostic factor for OS and disease-free survival (DFS 67 Enhanced BMI is a predictor of increased postoperative complications, including anastomotic leak, but it is not a predictor of survival in gastric cancer. Melis et al. 21 have reported that BMI does not affect the number of harvested lymph nodes, rates of negative margins, and morbidity and mortality after esophagectomy for cancer. In their experience, esophagectomy can be carried out safely and efficiently in mildly obese patients.
Miao et al. 68 have shown that high BMI is not associated with increased overall morbidity following esophagectomy; however, it is associated with a decreased incidence of chylothorax. However, better OS observed in patients having high BMI compared with those having low BMI might be attributed to a relatively low pathological stage. In summary, a high BMI should not be a relative contraindication for esophagectomy.
It has been shown that after colorectal resection, low BMI has a detrimental effect on long-term survival. Toiyama et al. have revealed that a BMI <20 is associated with reduced OS and DFS after laparoscopic resection. 69 Adachi et al. C, colectomy; CSS, cancer-specific survival; DFS, disease-free survival; DR, distant recurrence; LR, local recurrence; OR, overall recurrence; OS, overall survival; PBS, population-based study; PCS, prospective cohort study; R, rectal resection; RCS, retrospective cohort study. In addition to the low BMI, sarcopenia, defined as decreased muscle content, also has a negative impact on oncological outcome.
Levolger et al. 73 have reported that sarcopenia identified before surgery using single-slice computed tomography, is associated with impaired OS in gastrointestinal and hepatopancreatobiliary malignancies. Sarcopenia also increases postoperative morbidity in patients with colorectal cancer with or without hepatic metastases. also been associated with long-term survival. 37 Similarly, the Estimation of Physiological Ability and Surgical Stress scores 84 were associated with OS following gastrointestinal cancer resection. [85] [86] [87] The association between postoperative complications and reduced long-term survival in gastrointestinal cancer patients, whether or not these complications are detrimental for long-term survival, remains to be established owing to unmeasured confounders. It is possible that compromised statuses (potential confounders) simply cause postoperative complications as well as late mortality (Fig. 4) . For example, a diabetes mellitus patient with interstitial pneumonitis will have an increased chance of postoperative complications and a higher risk of tumor-related and unrelated death. To clarify the doubts persisting in this field, a large-scale prospective cohort study should be conducted.
Such a study should use a statistical method (e.g. propensity score adjustment) accounting for preoperative physiological status as well as systemic inflammatory response. As shown in Figure 4 , scanty adjuvant therapy is also considered one of the key intermediate fac-
tors affecting postoperative complications and long-term prognosis.
Greenleaf et al. have found that adjuvant therapy improves patient survival compared with patients not undergoing such therapy. However, the period before the initiation of adjuvant therapy did not affect survival among the treated patients. 88 Adjustments of intermediate variables in the standard statistical models should be conducted with caution because of a potential over-adjustment bias. 89 Recently, we carried out a mediation analysis to establish whether the effect of exposure on a particular outcome is mediated by a hypothesized intermediate variable. 90 Using such methods might shed some light on the causal relationship between postoperative complications and reduced long-term survival.
In conclusion, our literature review suggests that severe postoperative morbidities are associated with impaired long-term prognosis.
Avoiding such complications after radical surgery might improve oncological outcomes. Because there are no large-scale prospective cohort studies in this field, further multi-institutional prospective studies should be carried out.
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